CVA Family Office’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
VPM
VCM
AM
FAM
CVA Family Office's ALAB Position: Q1 2026 in Review
CVA Family Office increased its Astera Labs (ALAB) stake by 6.7% in Q1 2026, buying an estimated $285 and bringing the position to 32 shares worth $3.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1360.
CVA Family Office first reported a position in ALAB in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.99K in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.
- CVA Family Office held 32 shares of Astera Labs worth $3.51K as of Q1 2026.
- CVA Family Office bought 2 Astera Labs shares in Q1 2026, an estimated $285.
- Astera Labs made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1360 holding.
- CVA Family Office first reported a position in Astera Labs in Q1 2025 and has held it in 5 quarters since.
- CVA Family Office's Astera Labs position peaked at $4.99K in Q4 2025.
- 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.
Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.